News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Genomics Company NimbleGen Systems, Inc. Raises $8.2 Million In Late Stage Round
December 6, 2005
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
NimbleGen Systems Inc., a genomic analysis company, said that it has raised another $8.2 million in its Series F round of financing.
Twitter
LinkedIn
Facebook
Email
Print
Startups
MORE ON THIS TOPIC
Manufacturing
Lilly investing billions to prepare for overseas oral GLP-1 launches
April 14, 2026
·
2 min read
·
Nick Paul Taylor
Mergers & acquisitions
Lilly wants to bridge cancer care gap with $300M ADC biotech buy
April 14, 2026
·
1 min read
·
Gabrielle Masson
IPO
Kailera eyes record $533M+ IPO to play in competitive obesity space with Chinese drugs
April 14, 2026
·
2 min read
·
Tristan Manalac
Manufacturing
USP adds Tamiflu, Trulicity to vulnerable list as upstream analysis reshapes supply concerns
April 13, 2026
·
2 min read
·
Nick Paul Taylor
